Globus Medical Inc (GMED)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
David C. Paul
Employees:
1,800
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA 19403
610-930-1800

Globus Medical, Inc. is a medical device company, which focuses on developing products that promote healing in patients with musculoskeletal disorders. The company also focuses on products to treat patients with spine disorders. Its products fall into two categories: Innovative Fusion and Disruptive Technologies. The Innovative Fusion products comprise fusion products to treat a wide variety of spinal disorders for the entire spine and can be used in a variety of surgical approaches. The Disruptive Technologies as those that represent a significant shift in the treatment of spinal disorders by allowing for novel surgical procedures, improvements to existing surgical procedures and the treatment of spinal disorders earlier in the continuum of care. Globus Medical was founded by David Paul, David M. Demski and David D. Davidar in March 2003 and is headquartered in Audubon, PA.

Data derived from most recent annual or quarterly report
Market Cap 5.845 Billion Shares Outstanding101.558 Million Avg 30-day Volume 741.563 Thousand
P/E Ratio54.0966 Dividend Yield0.0 EPS0.86
Price to Revenue7.9879 Debt to Equity0.0 EBITDA236.481 Million
Price to Book Value4.3012 Operating Margin17.044500000000003 Enterprise Value6.659 Billion
Current Ratio6.478 EPS Growth0.142 Quick Ratio2.896
1 Yr BETA 0.9756 52-week High/Low 84.23 / 52.6 Profit Margin14.7659
Operating Cash Flow Growth16.9601 Altman Z-Score23.6764 Free Cash Flow to Firm 94.494 Million
View SEC Filings from GMED instead.

View recent insider trading info

Globus Medical Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding GMED (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding GMED BETA

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2022-04-21 by DAVIDAR DAVID D
  • 4: filed on 2022-04-11 by HULLER KELLY
  • 4: filed on 2022-03-17 by TOBIN JAMES R
  • 4: filed on 2022-02-07 by DAVIDAR DAVID D
  • 4: filed on 2022-01-31 by DOUGLAS ROBERT ANDREW
  • 4: filed on 2022-01-31 by ZARRILLI STEPHEN T
  • 4: filed on 2022-01-31 by TOBIN JAMES R
  • 4: filed on 2022-01-31 by RHOADS ANN D
  • 4: filed on 2022-01-31 by LEMAITRE DAN
  • 4: filed on 2022-01-31 by DAVIDAR DAVID D

    • Events (8k)

  • 8-K: filed on 2022-06-03:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-04-21:
    Item 2.02: Results of Operations and Financial Condition
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-04:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-02-17:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-11-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-08-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-06-04:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-05-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-02-17:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    SCAVILLA DANIEL T PRESIDENT, CEO

    • Officer
    • Director
    		 60,000 2022-04-21 3

    DAVIDAR DAVID D

    • Director
    		 807,242 2022-04-19 3

    HULLER KELLY SVP, GC, CORPORATE SECRETARY

    • Officer
    		 0 2022-04-08 2

    TOBIN JAMES R

    • Director
    		 26,666 2022-03-15 3

    ZARRILLI STEPHEN T

    • Director
    		 15,000 2022-01-27 1

    RHOADS ANN D

    • Director
    		 15,000 2022-01-27 1

    DOUGLAS ROBERT ANDREW

    • Director
    		 15,000 2022-01-27 1

    LEMAITRE DAN

    • Director
    		 15,000 2022-01-27 1

    PAUL DAVID C EXECUTIVE CHAIRMAN

    • Officer
    • Director
    • 10% Owner
    		 75,000 2022-01-27 1

    DEMSKI DAVID M PRESIDENT, CEO

    • Officer
    • Director
    		 150,000 2022-01-27 1

    PFEIL KEITH W SVP, CHIEF FINANCIAL OFFICER

    • Officer
    		 40,000 2022-01-27 5

    WILLIAMS ANTHONY L PRESIDENT

    • Officer
    		 0 2019-03-05 0

    PAYNE STEVEN CHIEF ACCOUNTING OFFICER

    • Officer
    		 0 2019-02-01 0

    LIPTAK ROBERT

    • Director
    		 0 2019-01-22 0

    WHEELER KURT

    • Director
    		 0 2019-01-22 0

    SCHWARTZ ERIC SENIOR VP AND GENERAL COUNSEL

    • Officer
    		 0 2018-06-25 0

    MURPHY A BRETT EVP, INTERNATIONAL SALES

    • Officer
    		 0 2018-02-02 0

    BARON RICHARD A

    • SENIOR VP
    		 No longer subject to file 2014-11-03 0

    CLARUS LIFESCIENCES I, L.P.

    CLARUS VENTURES I MANAGEMENT, L.P.

    CLARUS VENTURES I, LLC

    GALAKATOS NICHOLAS

    HENNER DENNIS

    LIPTAK ROBERT

    SIMON NICHOLAS

    STEINMETZ MICHAEL

    WHEELER KURT

    • 10% Owner
    • GENERAL PARTNERGP CLARUS VENTURES I MNGMT.MANAGING DIR. OF GPMANAGING DIR. OF GPMANAGING DIR. OF GPMANAGING DIR. OF GPMANAGING DIR. OF GPMANAGING DIR. OF GP
    		 No longer subject to file 2013-09-03 0

    GOLDMAN SACHS & CO

    GOLDMAN SACHS GROUP INC

    GS DIRECT, L.L.C.

    GOLDMAN SACHS INVESTMENT PARTNERS MASTER FUND, L.P.

    GOLDMAN SACHS INVESTMENT PARTNERS GP, LLC

    GOLDMAN SACHS PRIVATE EQUITY CONCENTRATED HEALTHCARE OFFSHORE ADVISORS,INC.

    GOLDMAN SACHS PRIVATE EQUITY CONCENTRATED HEALTHCARE FUND OFFSHORE HOLDINGS, L.P.

    GOLDMAN SACHS PRIVATE EQUITY PARTNERS 2004, L.P.

    GOLDMAN SACHS PEP 2004 ADVISORS, L.L.C.

    		0 2013-04-01 0

    GOLDMAN SACHS PEP 2004 OFFSHORE HOLDINGS ADVISORS, INC.

    GOLDMAN SACHS PRIVATE EQUITY PARTNERS 2004 OFFSHORE HOLDINGS, L.P.

    GOLDMAN SACHS PRIVATE EQUITY PARTNERS 2004 - DIRECT INVESTMENT FUND, L.P.

    GOLDMAN SACHS PEP 2004 DIRECT INVESTMENT ADVISORS, L.L.C.

    GOLDMAN SACHS PRIVATE EQUITY PARTNERS 2004 EMPLOYEE FUND, L.P.

    GOLDMAN SACHS PEP 2004 EMPLOYEE FUNDS GP, L.L.C.

    GS PRIVATE EQUITY PARTNERS 2002 - DIRECT INVESTMENT FUND, L.P.

    GS PEP 2002 DIRECT INVESTMENT ADVISORS, L.L.C.

    MULTI-STRATEGY HOLDINGS, L.P.

    MULTI-STRATEGY HOLDINGS OFFSHORE ADVISORS, INC.

    		0 2013-04-01 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    GLOBUS MEDICAL INC - A GMED 2022-06-29 22:15:03 UTC 1.32 0.25 1800000
    GLOBUS MEDICAL INC - A GMED 2022-06-29 21:45:05 UTC 1.32 0.25 1800000
    GLOBUS MEDICAL INC - A GMED 2022-06-29 21:15:03 UTC 1.32 0.25 1800000
    GLOBUS MEDICAL INC - A GMED 2022-06-29 20:45:03 UTC 1.32 0.25 1800000
    GLOBUS MEDICAL INC - A GMED 2022-06-29 20:15:04 UTC 1.32 0.25 1800000
    GLOBUS MEDICAL INC - A GMED 2022-06-29 19:45:03 UTC 1.32 0.25 1800000
    GLOBUS MEDICAL INC - A GMED 2022-06-29 19:15:04 UTC 1.32 0.25 1800000
    GLOBUS MEDICAL INC - A GMED 2022-06-29 18:45:03 UTC 1.32 0.25 1800000
    GLOBUS MEDICAL INC - A GMED 2022-06-29 18:15:03 UTC 1.32 0.25 1800000
    GLOBUS MEDICAL INC - A GMED 2022-06-29 17:45:03 UTC 1.32 0.25 1800000
    GLOBUS MEDICAL INC - A GMED 2022-06-29 17:15:03 UTC 1.32 0.25 1800000
    GLOBUS MEDICAL INC - A GMED 2022-06-29 16:45:03 UTC 1.32 0.25 1800000
    GLOBUS MEDICAL INC - A GMED 2022-06-29 16:15:03 UTC 1.32 0.25 1800000
    GLOBUS MEDICAL INC - A GMED 2022-06-29 15:45:03 UTC 1.32 0.25 1800000
    GLOBUS MEDICAL INC - A GMED 2022-06-29 15:15:03 UTC 1.32 0.25 1800000
    GLOBUS MEDICAL INC - A GMED 2022-06-29 14:45:03 UTC 1.32 0.25 1800000
    GLOBUS MEDICAL INC - A GMED 2022-06-29 14:15:03 UTC 1.32 0.25 1800000
    GLOBUS MEDICAL INC - A GMED 2022-06-29 13:45:03 UTC 1.32 0.25 1800000
    GLOBUS MEDICAL INC - A GMED 2022-06-29 13:15:03 UTC 1.32 0.25 1800000
    GLOBUS MEDICAL INC - A GMED 2022-06-29 12:45:02 UTC 1.32 0.25 1800000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Advisors Series Trust- Pzena Long/Short Value Fund GMED -2346.0 shares, $-128208.9 2020-05-31 N-PORT
    FundVantage Trust- Gotham Defensive Long Fund GMED -10.0 shares, $-425.3 2020-03-31 N-PORT
    AGF Investments Trust- AGFIQ U.S. Market Neutral Anti-Beta Fund GMED -8030.0 shares, $-592453.4 2022-03-31 N-PORT

    Elevate your investments